Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
Adagene of Suzhou Raises $8 Million for Antibody Discovery | December 8, 2014
WuXi PharmaTech Plans to List Subsidiary on China's Third Board | December 4, 2014
Oramed Pharma Raises $5 Million from Guangxi Wuzhou Zhongheng | December 3, 2014
IMS: China Pharma Revenues to Total $155-$185 Billion in 2018 | December 1, 2014
Sino Biopharma Invests up to $129 Million in Karolinska | November 17, 2014
BeiGene Raises $75 Million to Develop Oncology Drugs in China | November 15, 2014
>> See all top stories...
ChinaBio in the News